Clinical trial
A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa…
NCT00230815 · EMD Serono, Industry · Completed
Key facts
| NCT number | NCT00230815 |
|---|---|
| Title | A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction |
| Official title | A Phase IIIb, Prospective, Multicenter Trial to Evaluate Subject Satisfaction With Follitropin Alfa Injection Applied by Pen Device Compared With Other Injectable Gonadotropins in Oligoanovulatory Infertile Women Undergoing Ovulation Induction |
| Lead sponsor | EMD Serono, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Device |
| Interventions | Follitropin alfa injected by Pen device, Recombinant Human Choriogonadotropin (r-hCG) |
| Enrollment | 62 |
| Start date | Jul 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Oct 3, 2005 |
| Last update posted | Nov 28, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: